carnitine has been researched along with Arteriosclerosis in 15 studies
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic hemodialysis (HD) patients frequently encounter carnitine depletion, elevated adipose tissue-derived hormones/cytokines, that may contribute to accelerated arteriosclerosis." | 5.14 | L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis. ( Csiky, B; Melegh, B; Nyul, Z; Rascher, W; Rauh, M; Sulyok, E; Tóth, G; Wittmann, I, 2010) |
| " The authors, on the basis of recent studies demonstrating the rheological and vasoactive as well as metabolic activities of levocarnitine propionyl, have decided to use this substance in the treatment of arteriopathics affected by intermittent claudication." | 5.07 | Evaluation of the therapeutic efficacy and tolerability of levocarnitine propionyl in the treatment of chronic obstructive arteriopathies of the lower extremities: a multicentre controlled study vs. placebo. ( Coto, V; D'Alessandro, L; Grattarola, G; Imparato, L; Lingetti, M; Mancini, M; Nolfe, G; Rengo, F, 1992) |
| "Carnitine has a dual role as it is required for long-chain fatty acid oxidation, and also shuttles accumulated acyl groups out of the mitochondria." | 2.40 | The role of carnitine and carnitine supplementation during exercise in man and in individuals with special needs. ( Brass, EP; Hiatt, WR, 1998) |
| ") at a dosage of 1." | 1.28 | Cerebral blood flow in patients with chronic cerebrovascular disease: effect of acetyl L-carnitine. ( Cicerano, U; De Chiara, S; Gallotta, G; Mancini, M; Postiglione, A; Salvatore, M; Soricelli, A, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Csiky, B | 1 |
| Nyul, Z | 1 |
| Tóth, G | 1 |
| Wittmann, I | 1 |
| Melegh, B | 1 |
| Rauh, M | 1 |
| Rascher, W | 1 |
| Sulyok, E | 1 |
| Hiatt, WR | 2 |
| Lofgren, I | 1 |
| Zern, T | 1 |
| Herron, K | 1 |
| West, K | 1 |
| Sharman, MJ | 1 |
| Volek, JS | 1 |
| Shachter, NS | 1 |
| Koo, SI | 1 |
| Fernandez, ML | 1 |
| Lacour, B | 1 |
| Di Giulio, S | 1 |
| Chanard, J | 1 |
| Ciancioni, C | 1 |
| Haguet, M | 1 |
| Lebkiri, B | 1 |
| Basile, C | 1 |
| Drüeke, T | 1 |
| Assan, R | 1 |
| Funck-Brentano, JL | 1 |
| Maebashi, M | 1 |
| Imamura, A | 1 |
| Yoshinaga, K | 1 |
| Spagnoli, LG | 1 |
| Orlandi, A | 1 |
| Marino, B | 1 |
| Mauriello, A | 1 |
| De Angelis, C | 1 |
| Ramacci, MT | 1 |
| Brass, EP | 1 |
| Sayed-Ahmed, MM | 1 |
| Khattab, MM | 1 |
| Gad, MZ | 1 |
| Mostafa, N | 1 |
| Signorelli, SS | 1 |
| Malaponte, G | 1 |
| Di Pino, L | 1 |
| Digrandi, D | 1 |
| Pennisi, G | 1 |
| Mazzarino, MC | 1 |
| Coto, V | 1 |
| D'Alessandro, L | 1 |
| Grattarola, G | 1 |
| Imparato, L | 1 |
| Lingetti, M | 1 |
| Mancini, M | 2 |
| Nolfe, G | 1 |
| Rengo, F | 1 |
| Mimura, K | 1 |
| Yukawa, S | 1 |
| Postiglione, A | 1 |
| Cicerano, U | 1 |
| Soricelli, A | 1 |
| De Chiara, S | 1 |
| Gallotta, G | 1 |
| Salvatore, M | 1 |
| Kirk, JE | 2 |
| Hashimoto, S | 1 |
| Dayton, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina[NCT03696940] | Phase 3 | 120 participants (Actual) | Interventional | 2018-05-28 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for carnitine and Arteriosclerosis
| Article | Year |
|---|---|
Treatment of disability in peripheral arterial disease: new drugs.
Topics: Arteriosclerosis; Carnitine; Clinical Trials as Topic; Exercise Therapy; Humans; Hypolipidemic Agent | 2004 |
The role of carnitine and carnitine supplementation during exercise in man and in individuals with special needs.
Topics: Arteriosclerosis; Carnitine; Clinical Trials as Topic; Dietary Supplements; Energy Metabolism; Exerc | 1998 |
4 trials available for carnitine and Arteriosclerosis
| Article | Year |
|---|---|
L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis.
Topics: Adipokines; Aged; Aged, 80 and over; Arteriosclerosis; Carnitine; Female; Humans; Infusions, Intrave | 2010 |
Weight loss associated with reduced intake of carbohydrate reduces the atherogenicity of LDL in premenopausal women.
Topics: Adult; Arteriosclerosis; Caloric Restriction; Carnitine; Cholesterol, LDL; Dietary Carbohydrates; Di | 2005 |
Effects of ischaemic stress on leukocyte activation processes in patients with chronic peripheral occlusive arterial disease: role of L-propionyl carnitine administration.
Topics: Aged; Arteriosclerosis; Cardiotonic Agents; Carnitine; Cell Adhesion Molecules; Chronic Disease; E-S | 2001 |
Evaluation of the therapeutic efficacy and tolerability of levocarnitine propionyl in the treatment of chronic obstructive arteriopathies of the lower extremities: a multicentre controlled study vs. placebo.
Topics: Administration, Oral; Aged; Analysis of Variance; Arterial Occlusive Diseases; Arteriosclerosis; Car | 1992 |
9 other studies available for carnitine and Arteriosclerosis
| Article | Year |
|---|---|
Carnitine improves lipid anomalies in haemodialysis patients.
Topics: Adult; Arteriosclerosis; Carnitine; Cholesterol; Female; Humans; Kidney Failure, Chronic; Lipids; Li | 1980 |
Effect of aging on lipid and carnitine metabolism.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aging; Arteriosclerosis; Carnitine; Drug Synergism; Fatty | 1982 |
Propionyl-L-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits.
Topics: Aging; Animals; Arteriosclerosis; Carnitine; Cell Division; Diet; Disease Models, Animal; Female; Fo | 1995 |
L-carnitine prevents the progression of atherosclerotic lesions in hypercholesterolaemic rabbits.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Carnitine; Coronary Vessels; Hypercholesterolemia; Male; | 2001 |
[Hyperlipidemia and drug treatment].
Topics: Arteriosclerosis; Carnitine; Cholestyramine Resin; Glomerulonephritis; Humans; Hyperlipidemias; Kidn | 1991 |
Cerebral blood flow in patients with chronic cerebrovascular disease: effect of acetyl L-carnitine.
Topics: Acetylcarnitine; Aged; Arteriosclerosis; Carnitine; Cerebrovascular Circulation; Cerebrovascular Dis | 1990 |
Coenzyme contents of arterial tissue.
Topics: Age Factors; Animals; Aorta; Arteries; Arteriosclerosis; Carnitine; Chromatography, Paper; Coenzyme | 1974 |
Oxidation of palmityl-CoA to CO2 by normal and atherosclerotic aortic mitochondria.
Topics: Adenosine Diphosphate; Albumins; Animals; Aorta; Arteriosclerosis; Carbon Dioxide; Carbon Radioisoto | 1974 |
Carnitine (free carnitine).
Topics: Age Factors; Aging; Aorta; Arteries; Arteriosclerosis; Carnitine; Humans; Iliac Artery; Iliac Vein; | 1974 |